LOW-VOLUME · FEMALE-LED
methyldopa Side Effects
methyldopa (also sold as Aldomet) is a LOW-VOLUME FAERS extract #397 of 524 by FAERS report count. Still opens on FEMALE-LED: 74% of sex-coded reports are female (2,870 F / 1,010 M).
Data updated 2026-05-15
- 4,692
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
methyldopa reporting skew - 74% of sex-coded reports are female (2,870 F / 1,010 M). Volume band LOW-VOLUME #397 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for methyldopa (Aldomet) (4,692 reports #397 of 524 by FAERS report count). 74% of sex-coded reports are female (2,870 F / 1,010 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
FOETAL EXPOSURE DURING PREGNANCY leads 1,261 of 4,692 reports
FEMALE-LED reporters · age peak 18-44
Female-led reporters (74% of sex-coded rows)
Age peak 18-44 (1,514 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 217 reports (4.6% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| FOETAL EXPOSURE DURING PREGNANCY | 61 |
| PREMATURE BABY | 34 |
| DEATH | 30 |
| LOW BIRTH WEIGHT BABY | 19 |
| RESPIRATORY FAILURE | 19 |
| HYDROPS FOETALIS | 15 |
| CARDIAC ARREST | 14 |
| HYPERTENSION | 13 |
| PNEUMONIA | 13 |
| CARDIAC FAILURE | 12 |
| FOETAL GROWTH RESTRICTION | 12 |
| HYPOTENSION | 12 |
| MATERNAL EXPOSURE DURING PREGNANCY | 12 |
| ANAEMIA | 11 |
| NEUTROPENIA | 11 |
| PULMONARY HYPOPLASIA | 11 |
| RENAL FAILURE | 11 |
| THROMBOCYTOPENIA | 11 |
| CONGENITAL CYSTIC LUNG | 10 |
| FOETAL DEATH | 10 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (1,553, 33.1% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| MATERNAL EXPOSURE DURING PREGNANCY | 316 |
| FOETAL EXPOSURE DURING PREGNANCY | 218 |
| PREMATURE BABY | 197 |
| EXPOSURE DURING PREGNANCY | 196 |
| PREMATURE DELIVERY | 183 |
| HYPERTENSION | 152 |
| DYSPNOEA | 122 |
| LIVE BIRTH | 104 |
| PRE-ECLAMPSIA | 92 |
| BLOOD PRESSURE INCREASED | 86 |
| ANXIETY | 85 |
| LOW BIRTH WEIGHT BABY | 82 |
| VOMITING | 74 |
| NAUSEA | 68 |
| PYREXIA | 65 |
| FOETAL GROWTH RESTRICTION | 63 |
| HEADACHE | 62 |
| CAESAREAN SECTION | 59 |
How to read methyldopa FAERS figures (SIGNAL · DEATH-MARKED · HOSP-HEAVY)
FAERS holds 4,692 voluntary reports linked to methyldopa (Aldomet), 2004-2025. Death is listed on 217 (4.6%). Hospitalization appears on 1,553 (33.1%). Top co-reported indication: Hypertension.
Sparse extract - named reactions and FEMALE-LED skew still differ by drug; not a complete safety profile.
Read with methyldopa
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-HEAVY stamps.
ABS(total_reports) peer at 4,709 FAERS cases (Δ 17 heavier vs methyldopa); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 4,670 FAERS cases (Δ 22 lighter vs methyldopa); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 4,779 FAERS cases (Δ 87 heavier vs methyldopa); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 4,979 FAERS cases (Δ 287 heavier vs methyldopa); DEATH-HEAVY · HOSP-HEAVY · MALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-HEAVY · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 57.5 pp vs methyldopa's DEATH-MARKED): CASELOAD · HOSP-MID.
methyldopa stamps DEATH-MARKED · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.